Global Bone Tumor Ablation Devices Market Insights, Forecast to 2028

Bone tumors develop, when cells within a bone divide uncontrollably, forming a lump or mass of abnormal tissue. Most bone tumors are benign (not cancerous). Benign tumors are usually not life-threatening and in most cases, these tumors do not spread to other parts of the body. Depending upon the type of tumor, treatment options are wide-ranging, from clinical observation to surgery to remove the tumor.
Bone health significantly deteriorates with age, and this might lead to a large number of accidents and resultant fractures.
Several ablation techniques are available to treat bone tumors. They offer multiple advantages such as these techniques are minimally invasive, allow targeted tumor destruction, and have low rate of complications.
Market Analysis and Insights: Global Bone Tumor Ablation Devices Market
Due to the COVID-19 pandemic, the global Bone Tumor Ablation Devices market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Radiofrequency Ablation accounting for % of the Bone Tumor Ablation Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Bone Tumor Ablation Devices market size is valued at US$ million in 2021, while the US and Europe Bone Tumor Ablation Devices are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Bone Tumor Ablation Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Bone Tumor Ablation Devices include Medtronic Plc, Merit Medical Systems Inc, MedWaves Inc, AngioDynamics Inc, Olympus Corporation, Varian Medical Systems, Inc, Mermaid Medical, RF Medical Co., Ltd and Misomix Inc. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Bone Tumor Ablation Devices Scope and Segment
Bone Tumor Ablation Devices market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Bone Tumor Ablation Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
By Company
Medtronic Plc
Merit Medical Systems Inc
MedWaves Inc
AngioDynamics Inc
Olympus Corporation
Varian Medical Systems, Inc
Mermaid Medical
RF Medical Co., Ltd
Misomix Inc
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E